Q3 2025 Management View Justin Klee, Co-Founder, Co-CEO & Director, announced "Q3 was a quarter of progress as we continue to focus on our lead program, avexitide, in post-bariatric hypoglycemia or ...
Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing ...
Daewoong Pharmaceutical announced on November 3 that it will conduct large-scale recruitment in the second half of this year ...
ONO Pharmaceutical Co (($OPHLF)) announced an update on their ongoing clinical study. Study Overview: Ono Pharmaceutical Co. Ltd is conducting a ...
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 4, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...
Arrowhead Pharmaceuticals, Inc. ( (ARWR)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
DSMB Clearance to Proceed to the Next Dose Level of HG-CT-1 in Adult Patients, Opening Pediatric Recruitment, and Grant of Restricted Share Units to Hemogenyx Team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback